Skip to content
naulon
Not checkedNot checked for notices yet.

Introducing article numbering to Immuno-Oncology and Technology

C. O'Hara

Immuno-Oncology and Technology · 2021

doi:10.1016/j.iotech.2021.100026 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Within the publishing industry, article numbering has emerged as an easy and efficient way to cite journal articles. Article numbering has already been successfully rolled out to Elseviers multidisciplinary open access journal Heliyon, as well as more than 200 other journals, and has been well received by the academic community. Based on that positive feedback, we are now pleased to introduce article numbering to Immuno-Oncology and Technology. A unique article number is an abbreviated form of an articles DOI - digital object identifier. Citing an article with an article number is very simple: the article number is used instead of the page range in the citation. 2. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19:100205. https://doi.org/10.1016/j.heliyon.2018.100205. While journal volumes and issue numbers will remain in place, article numbering will now play the key role in identifying specific articles. The introduction of article numbers brings several benefits for the journal and its readers and authors. •More flexible reading: Article content can be optimized based on the device used to access it, supporting reading on-the-move, without needing to know how many traditional print pages the article takes up.•Increased options for grouping related content: In online collections and Special Issues, articles can now be placed in any order, helping readers to identify papers relevant to their research interests faster.•Faster publication: With article numbers, the version of record of the article is online and citable as soon as the proof corrections have been incorporated, ensuring readers have access to the latest research faster. We are delighted that Immuno-Oncology and Technologys readers and authors will now enjoy these benefits.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.